Ayush Rishi

Ayush Rishi

Active Director Director DIN 08753799
DIN 08753799 First appointment Jun 2020 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Ayush Rishi

Data last updated:

Ayush Rishi is a Director at A4 Pharma Private Limited (since 2020). The company operates in Business Outsourcing. A4 Pharma Private Limited reported revenue of ₹1,567 (FY 2025).

DIN 08753799
Primary Designation Director
Industry Business Outsourcing
First Appointment 06 Jun 2020
Oldest Company Age 10 yrs
Largest company A4 Pharma Private Limited · ₹1,567 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
A4 Pharma Private Limited U52100HR2015PTC057608
Director06 Jun 20202015₹1,567 (FY 2025)Active

Board colleagues of Ayush Rishi

NameDINCompanyDesignation
Anil Kumar03554100A4 Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
A4 Pharma Private Limited
Premium access

Shareholding and investment profile for Ayush Rishi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayush Rishi

Ayush Rishi currently holds 1 directorship: A4 Pharma Private Limited (Director, since 06 Jun 2020, revenue ₹1,567 (FY 2025)).

Ayush Rishi was first appointed on 06 Jun 2020 as Director at A4 Pharma Private Limited.

The current boards of Ayush Rishi's companies include Anil Kumar (A4 Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available